GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Asset Turnover

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Asset Turnover : 0.96 (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Nobel Biocare Holding AG's Revenue for the six months ended in Dec. 2013 was $776.4 Mil. Nobel Biocare Holding AG's Total Assets for the quarter that ended in Dec. 2013 was $812.1 Mil. Therefore, Nobel Biocare Holding AG's Asset Turnover for the quarter that ended in Dec. 2013 was 0.96.

Asset Turnover is linked to ROE % through Du Pont Formula. Nobel Biocare Holding AG's annualized ROE % for the quarter that ended in Dec. 2013 was 26.58%. It is also linked to ROA % through Du Pont Formula. Nobel Biocare Holding AG's annualized ROA % for the quarter that ended in Dec. 2013 was 14.36%.


Nobel Biocare Holding AG Asset Turnover Historical Data

The historical data trend for Nobel Biocare Holding AG's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Asset Turnover Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 0.74 0.83 0.97 0.96

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.74 0.83 0.97 0.96

Competitive Comparison of Nobel Biocare Holding AG's Asset Turnover

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nobel Biocare Holding AG's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's Asset Turnover falls into.



Nobel Biocare Holding AG Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Nobel Biocare Holding AG's Asset Turnover for the fiscal year that ended in Dec. 2013 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2013 )/( (Total Assets (A: Dec. 2012 )+Total Assets (A: Dec. 2013 ))/ count )
=776.422/( (788.762+835.514)/ 2 )
=776.422/812.138
=0.96

Nobel Biocare Holding AG's Asset Turnover for the quarter that ended in Dec. 2013 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2013 )/( (Total Assets (Q: Dec. 2012 )+Total Assets (Q: Dec. 2013 ))/ count )
=776.422/( (788.762+835.514)/ 2 )
=776.422/812.138
=0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Nobel Biocare Holding AG  (OTCPK:NBHGF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Nobel Biocare Holding AG's annulized ROE % for the quarter that ended in Dec. 2013 is

ROE %**(Q: Dec. 2013 )
=Net Income/Total Stockholders Equity
=116.654/438.835
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(116.654 / 1552.844)*(1552.844 / 812.138)*(812.138/ 438.835)
=Net Margin %*Asset Turnover*Equity Multiplier
=7.51 %*1.912*1.8507
=ROA %*Equity Multiplier
=14.36 %*1.8507
=26.58 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2013) net income data. The Revenue data used here is two times the semi-annual (Dec. 2013) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Nobel Biocare Holding AG's annulized ROA % for the quarter that ended in Dec. 2013 is

ROA %(Q: Dec. 2013 )
=Net Income/Total Assets
=116.654/812.138
=(Net Income / Revenue)*(Revenue / Total Assets)
=(116.654 / 1552.844)*(1552.844 / 812.138)
=Net Margin %*Asset Turnover
=7.51 %*1.912
=14.36 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2013) net income data. The Revenue data used here is two times the semi-annual (Dec. 2013) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Nobel Biocare Holding AG Asset Turnover Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines